Acute Myeloblastic Leukemia Type 1

Search Trials
Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy
Status:
Terminated
Last Changed:
Jun 19, 2015
First Changed:
Jan 31, 2012
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
cholecalciferolpharmacological studycholecalciferollaboratory biomarker analysis
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Jul 24, 2018
First Changed:
May 22, 2014
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
choline magnesium trisalicylateidarubicincytarabinelaboratory biomarker analysis
Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Mar 10, 2017
First Changed:
Jan 8, 2014
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
ixazomib
Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
Apr 24, 2018
First Changed:
Apr 1, 2013
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
SirolimusIdarubicinCytarabine
MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
Dec 6, 2017
First Changed:
Jan 30, 2014
Disease(s):
Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Intervention(s):
MEK inhibitor MEK162idarubicincytarabinepharmacological studylaboratory biomarker analysis

Connect. Empower. Inspire.